Demant's hearing implant division struggled with recalls and pandemic pressure

From the second half of 2022, Demant will no longer sell hearing implants. The company’s implant division, Oticon Medical, has been challenged by past recalls and the pandemic situation, says CEO Søren Nielsen.
Søren Nielsen, CEO of Demant | Photo: Demant / PR
Søren Nielsen, CEO of Demant | Photo: Demant / PR
by marketwire, translated by daniel pedersen

Hearing aid manufacturer Demant has just announced its intention to divest its business division that has long been outwardly signaled to be one of its strategically important areas.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Foto: Mike Blake/Reuters/Ritzau Scanpix

    Gilead Sciences CMO to leave early 2025

    For subscribers

    Further reading